« Previous
Next »
Subjects
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy[remove]2
- Treatment Outcome2
- United States2
- Administration, Oral1
- Antibodies, Monoclonal -- therapeutic use1
- Antirheumatic Agents -- adverse effects1
- Antirheumatic Agents -- economics1
- Antirheumatic Agents -- therapeutic use1
- Benchmarking1
- Comparative Effectiveness Research1
- Cost-Benefit Analysis1
- Humans1
- Immunosuppressive Agents -- adverse effects1
- Immunosuppressive Agents -- economics1
- Immunosuppressive Agents -- therapeutic use1
- Insurance Coverage1
- Multiple Sclerosis, Chronic Progressive -- drug therapy1
- Randomized Controlled Trials as Topic1